Objectives: To investigate the distribution of muscle weakness in Myasthenia gravis (MG)
and the therapeutic response in each category. Methods: This is a retrospective cross …

Objectives: To report demographic and clinical data on 98 myasthenia gravis (MG) patients,
seen over 5 years (January 2014-December 2018). Methods: This was a retrospective …

Introduction: A limited number of research studies were published to delineate the clinical
pattern of myasthenia gravis in Saudi Arabia. This paper is an attempt to describe some of …

Myasthenia gravis (MG) has a cosmopolitan distribution and can affect people of all
agegroup. Sometimes atypical presentation causes difficulty in the early diagnosis and …

Background: Myasthenia Gravis (MG) is a potentially treatable disease among many
neuromuscular disorders. Different demographic, clinical and laboratory characteristics may …

Background: Myasthenia gravis (MG) affects the neuromuscular transmission, causing
fluctuating muscle weakness and fatigue. This study is carried out with the aim to study the …

Background: Myasthenia gravis (MG), an autoimmune disease, affects the neuromuscular
junction. The impaired neuromuscular transmission results in fatigable muscle weakness …

Purpose Myasthenia gravis (MG) is a potentially fatal neuromuscular disorder if left
untreated. In this study, we tried to address the possible demographic, clinical, and …

Objectives: Objectives: To report clinical and laboratory features and outcomes of patients
with autoimmune myasthenia gravis (MG) recruited from a single center in Saudi Arabia …

Objective: This study aimed to analyze the demographic, clinical, electrophysiological, and
immunological features of patients with myasthenia gravis (MG) diagnosed at the outpatient …